Balance Sheet Avacta Group Plc

Stocks

AVCT

GB00BYYW9G87

Biotechnology & Medical Research

Delayed London S.E. Other stock markets 15:57:48 16/06/2026 BST			5-day change	1st Jan Change
72.75 ^GBX	+2.46%		+2.68%	+24.81%

06-05	Avacta Group raises GBP9 million for bond repayments	AN
06-05	Avacta Therapeutics Raises GBP9 Million from Share Issue	MT

93c98a50a41c4828462b671212e4ed14.ny1GzIH_yP-p3OdT2CQwJmzAV28eBrYNalUI2T3n5kg.-n4lpcyaobfOjKBgkW0GYFuvETlVX-FJBThAqRCkgib7Zn6p1cz_vcaOkA

Published financial data: AVACTA GROUP PLC

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	3.64M	2.94M	9.65M	23.25M	113K
Total Revenues	3.64M	2.94M	9.65M	23.25M	113K
Cost of Goods Sold, Total	2.46M	3.89M	3.46M	12M	-
Gross Profit	1.17M	-947K	6.19M	11.24M	113K
Selling General & Admin Expenses, Total	7.32M	8.14M	11.23M	16.86M	12.05M
Stock-Based Compensation (IS)	3.11M	5.06M	7.49M	2.91M	4.11M
R&D Expenses	8.96M	13.48M	11.1M	14.53M	14.27M
Depreciation & Amortization - (IS)	1.12M	1.46M	1.9M	2.64M	1.49M
Amortization of Goodwill and Intangible Assets - (IS)	-	-	-	1.03M	16K
Other Operating Expenses, Total	20.51M	28.14M	31.73M	37.96M	31.92M
Operating Income	-19.34M	-29.08M	-25.53M	-26.72M	-31.81M
Interest Expense, Total	-93K	-128K	-2.7M	-15.3M	-10.09M
Interest And Investment Income	43K	17K	91K	655K	663K
Net Interest Expenses	-50K	-111K	-2.61M	-14.64M	-9.43M
Income (Loss) On Equity Invest.	-217K	-	-1.15M	-847K	-747K
Other Non Operating Income (Expenses)	-	-	-4.1M	15.68M	13M
EBT, Excl. Unusual Items	-19.6M	-29.19M	-33.4M	-26.52M	-28.98M
Merger & Related Restructuring Charges	-	-	-3.02M	-282K	-
Impairment of Goodwill	-	-	-	-	-
Asset Writedown	-1.74M	-	-5.22M	-512K	-
EBT, Incl. Unusual Items	-21.34M	-29.19M	-41.64M	-27.32M	-28.98M
Income Tax Expense	-2.45M	-2.82M	-2.1M	-2.37M	444K
Earnings From Continuing Operations	-18.89M	-26.37M	-39.54M	-24.95M	-29.43M
Earnings Of Discontinued Operations	-	58K	351K	-	-23.41M
Net Income to Company	-18.89M	-26.32M	-39.19M	-24.95M	-52.84M
Net Income - (IS)	-18.89M	-26.32M	-39.19M	-24.95M	-52.84M
Net Income to Common Incl Extra Items	-18.89M	-26.32M	-39.19M	-24.95M	-52.84M
Net Income to Common Excl. Extra Items	-18.89M	-26.37M	-39.54M	-24.95M	-29.43M
Per Share Items
Net EPS - Basic	-0.08	-0.11	-0.15	-0.09	-0.15
Basic EPS - Continuing Operations	-0.08	-0.11	-0.15	-0.09	-0.09
Basic Weighted Average Shares Outstanding	226M	249M	255M	273M	345M
Net EPS - Diluted	-0.08	-0.11	-0.15	-0.09	-0.15
Diluted EPS - Continuing Operations	-0.08	-0.11	-0.15	-0.09	-0.09
Diluted Weighted Average Shares Outstanding	226M	249M	255M	273M	345M
Normalized Basic EPS	-0.05	-0.07	-0.08	-0.06	-0.05
Normalized Diluted EPS	-0.05	-0.07	-0.08	-0.06	-0.05
Supplemental Items
EBITDA	-18.45M	-27.61M	-24.34M	-24.62M	-30.37M
EBITA	-19.33M	-29.08M	-25.36M	-25.75M	-31.8M
EBIT	-19.34M	-29.08M	-25.53M	-26.72M	-31.81M
EBITDAR	-18.45M	-27.58M	-24.3M	-24.4M	-30.21M
Effective Tax Rate - (Ratio)	11.49	9.66	5.05	8.68	-1.53
Current Domestic Taxes	-	-	-	-	-
Current Foreign Taxes	-	-	-	-	-1.82M
Total Current Taxes	-2.45M	-2.82M	-2.04M	-2.09M	-1.82M
Deferred Foreign Taxes	-	-	-	-	2.27M
Total Deferred Taxes	-	-	-63K	-279K	2.27M
Normalized Net Income	-12.25M	-18.25M	-20.87M	-16.58M	-18.11M
Interest on Long-Term Debt	93K	138K	2.83M	15.3M	10.21M
Supplemental Operating Expense Items
General and Administrative Expenses	-	-	-	-	-
Research And Development Expense From Footnotes	9.97M	14.3M	17.15M	14.58M	14.27M
Net Rental Expense, Total	2K	29K	42K	222K	157K
Imputed Operating Lease Interest Expense	1.04K	15.86K	28.08K	519K	357K
Imputed Operating Lease Depreciation	961	13.14K	13.92K	-297K	-200K
Stock-Based Comp., G&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., Other (Total)	3.11M	5.06M	7.49M	2.91M	4.11M
Total Stock-Based Compensation	3.11M	5.06M	7.49M	2.91M	4.11M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	27.89M	26.19M	41.78M	16.63M	12.87M
Short Term Investments	20.02M	-	-	-	-
Total Cash And Short Term Investments	47.91M	26.19M	41.78M	16.63M	12.87M
Accounts Receivable, Total	1.57M	1.3M	2.47M	3.27M	-
Other Receivables	2.48M	3.31M	7.86M	3.86M	3.38M
Total Receivables	4.06M	4.61M	10.33M	7.12M	3.38M
Inventory	248K	189K	1.68M	2.58M	-
Prepaid Expenses	1.04M	2.47M	1.76M	1.7M	1.03M
Other Current Assets, Total	-	1.28M	-	-	22.92M
Total Current Assets	53.25M	34.74M	55.55M	28.04M	40.2M
Gross Property Plant And Equipment	9.8M	10.17M	13.27M	15.93M	6.51M
Accumulated Depreciation	-5.01M	-5.83M	-5.47M	-5.94M	-3.73M
Net Property Plant And Equipment	4.79M	4.34M	7.8M	9.99M	2.78M
Long-term Investments	-	-	2.98M	4.08M	3.44M
Goodwill	2.32M	1.54M	14.23M	17.04M	1.54M
Other Intangibles, Total	234K	340K	12.09M	13.09M	305K
Deferred Tax Assets Long-Term	-	-	-	253K	-
Deferred Charges Long-Term	6.87M	6.05M	0	712K	0
Total Assets	67.46M	47M	92.65M	73.19M	48.27M
Liabilities
Accounts Payable, Total	856K	561K	2.49M	3.73M	2.8M
Accrued Expenses, Total	1.82M	2.84M	3.77M	4.03M	2.91M
Short-term Borrowings	-	-	18.73M	16.1M	20.5M
Current Portion of Long-Term Debt	-	-	39.1M	18.49M	1.28M
Current Portion of Leases	290K	291K	1.36M	1.3M	956K
Current Income Taxes Payable	232K	210K	876K	1.05M	136K
Unearned Revenue Current, Total	579K	51K	1.14M	302K	-
Other Current Liabilities	5K	419K	152K	118K	8.73M
Total Current Liabilities	3.78M	4.37M	67.61M	45.11M	37.3M
Long-Term Debt	-	-	-	219K	-
Long-Term Leases	1.75M	1.41M	3.75M	5.74M	1.48M
Deferred Tax Liability Non Current	-	-	2.84M	323K	-
Other Non Current Liabilities	-	-	-	-	208K
Total Liabilities	5.53M	5.78M	74.21M	51.39M	38.99M
Common Stock, Total	25.27M	25.4M	26.61M	28.42M	36.94M
Additional Paid In Capital	54.14M	54.53M	62.18M	83.22M	116M
Retained Earnings	-12.86M	-34.09M	-66M	-85.75M	-139M
Treasury Stock	-2.96M	-2.96M	-2.76M	-2.48M	-2.37M
Comprehensive Income and Other	-1.65M	-1.65M	-1.6M	-1.6M	-2.04M
Total Common Equity	61.93M	41.22M	18.44M	21.8M	9.28M
Total Equity	61.93M	41.22M	18.44M	21.8M	9.28M
Total Liabilities And Equity	67.46M	47M	92.65M	73.19M	48.27M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	250M	250M	272M	357M	389M
ECS Total Common Shares Outstanding	249M	250M	262M	281M	366M
Book Value / Share	0.25	0.17	0.07	0.08	0.03
Tangible Book Value	59.38M	39.34M	-7.89M	-8.32M	7.44M
Tangible Book Value Per Share	0.24	0.16	-0.03	-0.03	0.02
Total Debt	2.04M	1.7M	62.94M	41.84M	24.22M
Net Debt	-45.87M	-24.49M	21.16M	25.21M	11.34M
Debt Equivalent Oper. Leases	16K	232K	336K	1.78M	1.26M
Equity Method Investments, Total	-	-	2.98M	4.08M	3.44M
Account Code - Inventory Valuation	5	5	5	5	6
Inventories - Raw Materials, Total	207K	189K	198K	871K	-
Inventories - Work In Process, Total	-	-	-	399K	-
Inventories - Finished Goods, Total	41K	-	1.48M	1.32M	-
Machinery, Total	5.49M	5.86M	6.46M	7.22M	3.13M
Full Time Employees	123	133	120	154	151

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-18.89M	-26.32M	-39.19M	-24.95M	-52.84M
Depreciation & Amortization - CF	1.12M	1.46M	1.95M	2.64M	1.43M
Amortization of Goodwill and Intangible Assets - (CF)	4K	8K	172K	971K	16K
Depreciation & Amortization, Total	1.13M	1.47M	2.12M	3.61M	1.44M
Amortization of Deferred Charges, Total - (CF)	1.02M	857K	879K	62K	-
(Gain) Loss From Sale Of Asset	6K	30K	52K	-2K	9K
Asset Writedown & Restructuring Costs	1.74M	-	5.22M	512K	-
(Income) Loss On Equity Investments - (CF)	217K	-	1.15M	847K	747K
Stock-Based Compensation (CF)	3.11M	5.08M	7.49M	2.91M	4.11M
Net Cash From Discontinued Operations	-	50K	-297K	-	1.34M
Other Operating Activities, Total	301K	-549K	2.26M	1.38M	21.28M
Change In Accounts Receivable	-814K	-1.6M	2.22M	841K	-244K
Change In Inventories	-91K	13K	52K	196K	-
Change In Accounts Payable	1.63M	456K	1.6M	-301K	557K
Change in Unearned Revenues	-	-	-	28K	-
Cash from Operations	-10.64M	-20.51M	-16.43M	-14.87M	-23.6M
Capital Expenditure	-1.28M	-1.16M	-558K	-1.12M	-323K
Sale of Property, Plant, and Equipment	-	-	50K	60K	-
Cash Acquisitions	-	-	-24.88M	-7.8M	-
Sale (Purchase) of Intangible assets	-386K	-152K	-36K	-96K	-16K
Investment in Marketable and Equity Securities, Total	-20.23M	20.02M	-	-	-
Other Investing Activities, Total	-	-	380K	-42K	-1.09M
Cash from Investing	-21.9M	18.7M	-25.04M	-9M	-1.43M
Long-Term Debt Issued, Total	-	-	52.25M	-	-
Total Debt Issued	-	-	52.25M	-	-
Long-Term Debt Repaid, Total	-255K	-290K	-800K	-1.7M	-3.46M
Total Debt Repaid	-255K	-290K	-800K	-1.7M	-3.46M
Issuance of Common Stock	54.86M	522K	9.49M	398K	31.88M
Other Financing Activities, Total	-2.96M	-	-4.03M	-	-2.32M
Cash from Financing	51.65M	232K	56.9M	-1.3M	26.1M
Foreign Exchange Rate Adjustments	-	4K	160K	17K	84K
Miscellaneous Cash Flow Adjustments	-	-136K	-	-	-
Net Change in Cash	19.11M	-1.7M	15.59M	-25.15M	1.15M
Supplemental Items
Cash Interest Paid	93K	139K	202K	315K	138K
Cash Income Tax Paid (Refund)	-	-	168K	-6.63M	-1.17M
Levered Free Cash Flow	-7.44M	-14.8M	-8.63M	-17.74M	-31.55M
Unlevered Free Cash Flow	-7.38M	-14.72M	-6.94M	-8.18M	-25.24M
Change In Net Working Capital	-1.11M	2.62M	879K	-3.16M	10.57M
Net Debt Issued / Repaid	-255K	-290K	51.45M	-1.7M	-3.46M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-25.21	-31.76	-22.85	-20.1	-32.74
Return on Total Capital	-26.68	-34.01	-25.68	-22.63	-40.93
Return On Equity %	-43.06	-51.14	-132.55	-116.57	-224.77
Return on Common Equity	-43.06	-51.14	-132.55	-116.57	-224.77
Margin Analysis
Gross Profit Margin %	32.29	-32.2	64.16	48.37	100
SG&A Margin	201.18	276.64	116.36	72.5	10.66K
EBITDA Margin %	-507.43	-938.93	-252.18	-105.89	-26.87K
EBITA Margin %	-531.66	-988.61	-262.73	-110.75	-28.14K
EBIT Margin %	-531.77	-988.88	-264.51	-114.93	-28.15K
Income From Continuing Operations Margin %	-519.55	-896.77	-409.61	-107.31	-26.04K
Net Income Margin %	-519.55	-894.8	-405.98	-107.31	-46.76K
Net Avail. For Common Margin %	-519.55	-896.77	-409.61	-107.31	-26.04K
Normalized Net Income Margin	-336.94	-620.41	-216.22	-71.31	-16.03K
Levered Free Cash Flow Margin	-204.55	-503.33	-89.38	-76.31	-27.92K
Unlevered Free Cash Flow Margin	-202.95	-500.61	-71.9	-35.18	-22.34K
Asset Turnover
Asset Turnover	0.08	0.05	0.14	0.28	0
Fixed Assets Turnover	0.92	0.64	1.59	2.61	0.02
Receivables Turnover (Average Receivables)	3.21	2.05	5.13	8.1	-
Inventory Turnover (Average Inventory)	12.19	17.79	3.7	5.63	-
Short Term Liquidity
Current Ratio	14.08	7.95	0.82	0.62	1.08
Quick Ratio	13.74	7.05	0.77	0.53	0.44
Operating Cash Flow to Current Liabilities	-2.81	-4.69	-0.24	-0.33	-0.63
Days Sales Outstanding (Average Receivables)	113.9	178.09	71.22	45.04	-
Days Outstanding Inventory (Average Inventory)	30.03	20.51	98.63	64.86	-
Average Days Payable Outstanding	111.35	67.54	112.33	87.91	-
Cash Conversion Cycle (Average Days)	32.58	131.07	57.52	21.99	-
Long Term Solvency
Total Debt/Equity	3.3	4.13	341.38	191.87	260.92
Total Debt / Total Capital	3.19	3.97	77.34	65.74	72.29
LT Debt/Equity	2.83	3.43	20.35	27.31	15.97
Long-Term Debt / Total Capital	2.74	3.29	4.61	9.36	4.42
Total Liabilities / Total Assets	8.2	12.3	80.1	70.21	80.77
EBIT / Interest Expense	-207.9	-227.21	-9.45	-1.75	-3.15
EBITDA / Interest Expense	-195.76	-215.73	-8.67	-1.51	-3.01
(EBITDA - Capex) / Interest Expense	-209.52	-224.81	-8.87	-1.58	-3.04
Total Debt / EBITDA	-0.11	-0.06	-2.69	-1.81	-0.8
Net Debt / EBITDA	2.52	0.89	-0.9	-1.09	-0.37
Total Debt / (EBITDA - Capex)	-0.1	-0.06	-2.63	-1.73	-0.79
Net Debt / (EBITDA - Capex)	2.35	0.85	-0.88	-1.04	-0.37
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-6.53	37.17	228.22	140.83	-96.04
Gross Profit, 1 Yr. Growth %	-11.01	-364.53	-753.96	55.24	-96.02
EBITDA, 1 Yr. Growth %	57.51	57.51	-12.84	1.13	46.53
EBITA, 1 Yr. Growth %	52.63	56.36	-12.77	1.52	44.5
EBIT, 1 Yr. Growth %	51.93	56.37	-12.21	4.64	44.58
Earnings From Cont. Operations, 1 Yr. Growth %	71.39	60.85	49.92	-32.54	0.95
Net Income, 1 Yr. Growth %	71.39	39.3	48.92	-31.9	58.89
Normalized Net Income, 1 Yr. Growth %	53.81	54.78	14.39	-20.58	-6.03
Diluted EPS Before Extra, 1 Yr. Growth %	-8.57	45.44	46.46	-36.83	-20.11
Accounts Receivable, 1 Yr. Growth %	127.97	-17.55	90.44	32.27	-
Inventory, 1 Yr. Growth %	58.97	-23.79	789.42	53.78	-
Net Property, Plant and Equip., 1 Yr. Growth %	55.35	-9.39	79.64	28.06	-72.11
Total Assets, 1 Yr. Growth %	137.46	-30.33	97.12	-21.23	-34.05
Tangible Book Value, 1 Yr. Growth %	170.63	-33.74	-120.04	56.13	-156.25
Common Equity, 1 Yr. Growth %	139.95	-33.44	-55.27	3.86	-45.09
Cash From Operations, 1 Yr. Growth %	15.84	92.69	-19.87	-9.49	58.67
Capital Expenditures, 1 Yr. Growth %	193.19	-9.15	-51.98	101.43	57.56
Levered Free Cash Flow, 1 Yr. Growth %	-	109.23	-41.61	105.6	94.03
Unlevered Free Cash Flow, 1 Yr. Growth %	-	109.75	-52.78	17.84	262.29
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-13.05	112.19	181.15	-89.18
Gross Profit, 2 Yr. CAGR %	-	-15.28	315.92	244.58	-87.51
EBITDA, 2 Yr. CAGR %	-	53.54	17.83	-6.12	11.69
EBITA, 2 Yr. CAGR %	-	51.52	16.78	-5.9	11.97
EBIT, 2 Yr. CAGR %	-	51.17	17.17	-4.15	11.62
Earnings From Cont. Operations, 2 Yr. CAGR %	-	54.69	55.29	-2.74	-10.8
Net Income, 2 Yr. CAGR %	-	54.52	44.03	-2.64	20.1
Normalized Net Income, 2 Yr. CAGR %	-	51.35	33.06	-4.68	-6.84
Diluted EPS Before Extra, 2 Yr. CAGR %	-	7.43	45.95	-6.97	-23.21
Accounts Receivable, 2 Yr. CAGR %	-	37.1	25.31	58.71	-
Inventory, 2 Yr. CAGR %	-	10.07	160.35	269.83	-
Net Property, Plant and Equip., 2 Yr. CAGR %	-	18.64	27.58	51.67	-40.24
Total Assets, 2 Yr. CAGR %	-	28.62	17.19	24.79	-27.93
Tangible Book Value, 2 Yr. CAGR %	-	33.91	-63.56	-54.01	18.13
Common Equity, 2 Yr. CAGR %	-	26.38	-45.44	-27.27	-33.51
Cash From Operations, 2 Yr. CAGR %	-	49.4	24.26	-14.84	19.83
Capital Expenditures, 2 Yr. CAGR %	-	63.21	-33.95	-1.65	-23.92
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	10.43	9.56	91.22
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	-0.57	-25.41	90.72
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	35.38	121.33	-66.26
Gross Profit, 3 Yr. CAGR %	-	-	67.44	215.51	-50.77
EBITDA, 3 Yr. CAGR %	-	-	27.61	11.98	2.83
EBITA, 3 Yr. CAGR %	-	-	26.04	11.46	3.03
EBIT, 3 Yr. CAGR %	-	-	26.12	12.83	3.03
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	53.08	15.01	3.72
Net Income, 3 Yr. CAGR %	-	-	52.63	9.71	26.16
Normalized Net Income, 3 Yr. CAGR %	-	-	37.87	12.03	-0.24
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	19.12	7.97	-6.87
Accounts Receivable, 3 Yr. CAGR %	-	-	52.97	27.59	-
Inventory, 3 Yr. CAGR %	-	-	120.88	118.44	-
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	36.24	27.74	-13.75
Total Assets, 3 Yr. CAGR %	-	-	48.29	2.75	0.89
Tangible Book Value, 3 Yr. CAGR %	-	-	-28.9	-48.06	-42.61
Common Equity, 3 Yr. CAGR %	-	-	-10.6	-29.39	-39.16
Cash From Operations, 3 Yr. CAGR %	-	-	21.39	11.8	4.79
Capital Expenditures, 3 Yr. CAGR %	-	-	8.55	-4.21	-34.74
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	35.85	28.77
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	5.22	19.76
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	-	-50.73
Gross Profit, 5 Yr. CAGR %	-	-	-	-	-38.83
EBITDA, 5 Yr. CAGR %	-	-	-	-	20.99
EBITA, 5 Yr. CAGR %	-	-	-	-	20.21
EBIT, 5 Yr. CAGR %	-	-	-	-	20.11
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	-	21.7
Net Income, 5 Yr. CAGR %	-	-	-	-	36.82
Normalized Net Income, 5 Yr. CAGR %	-	-	-	-	17.86
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-	-1.39
Accounts Receivable, 5 Yr. CAGR %	-	-	-	-	-
Inventory, 5 Yr. CAGR %	-	-	-	-	-
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	-	-2.02
Total Assets, 5 Yr. CAGR %	-	-	-	-	11.18
Tangible Book Value, 5 Yr. CAGR %	-	-	-	-	-19.46
Common Equity, 5 Yr. CAGR %	-	-	-	-	-18.5
Cash From Operations, 5 Yr. CAGR %	-	-	-	-	20.76
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-	-5.83
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	-
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	-